Healthcare provider profile · identity verified

Raman Kumar Talwar, MD

General Surgery · PALMDALE, CA · NPI 1922188572

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	565	62
Lisinopril	Lisinopril	228	31
Omeprazole	Omeprazole	194	28
Furosemide	Furosemide	193	24
Metformin Hcl	Metformin Hcl	171	23
Levothyroxine Sodium	Levothyroxine Sodium	161	18
Amlodipine Besylate	Amlodipine Besylate	158	18
Gabapentin	Gabapentin	148	19
Famotidine	Famotidine	129	20
Pantoprazole Sodium	Pantoprazole Sodium	119	19
Metoprolol Succinate	Metoprolol Succinate	114	16
Losartan Potassium	Losartan Potassium	108	14
Tamsulosin Hcl	Tamsulosin Hcl	105	13
Hydrochlorothiazide	Hydrochlorothiazide	101	suppressed
Clopidogrel	Clopidogrel Bisulfate	94	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	21
Metoprolol Tartrate	Metoprolol Tartrate	88	12
Potassium Chloride	Potassium Chloride	88	12
Rosuvastatin Calcium	Rosuvastatin Calcium	88	suppressed
Trazodone Hcl	Trazodone Hcl	85	16
Eliquis	Apixaban	82	11
Montelukast Sodium	Montelukast Sodium	81	suppressed
Trulicity	Dulaglutide	81	14
Fluticasone Propionate	Fluticasone Propionate	77	18
Spironolactone	Spironolactone	73	suppressed
Carvedilol	Carvedilol	69	suppressed
Pregabalin	Pregabalin	69	suppressed
Benazepril Hcl	Benazepril Hcl	67	suppressed
Clonidine Hcl	Clonidine Hcl	67	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	59	suppressed
Sertraline Hcl	Sertraline Hcl	58	suppressed
Latanoprost	Latanoprost	53	suppressed
Jardiance	Empagliflozin	49	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	48	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	14
Pravastatin Sodium	Pravastatin Sodium	47	suppressed
Amiodarone Hcl	Amiodarone Hcl	46	suppressed
Ibuprofen	Ibuprofen	46	21
Allopurinol	Allopurinol	45	suppressed
Mirtazapine	Mirtazapine	42	suppressed
Amoxicillin	Amoxicillin	41	22
Hydralazine Hcl	Hydralazine Hcl	39	suppressed
Buspirone Hcl	Buspirone Hcl	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	34	11
Calcitriol	Calcitriol	34	suppressed
Lorazepam	Lorazepam	33	suppressed
Levetiracetam	Levetiracetam	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Spiriva Respimat	Tiotropium Bromide	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Clonazepam	Clonazepam	28	suppressed
Nystatin	Nystatin	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Finasteride	Finasteride	27	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Azithromycin	Azithromycin	25	15
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	12
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	14
Dapagliflozin	Dapagliflozin Propanediol	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Nystop	Nystatin	19	11
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Glipizide	Glipizide	18	suppressed
Insulin Aspart Flexpen	Insulin Aspart	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	suppressed
Invokana	Canagliflozin	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Simvastatin	Simvastatin	14	suppressed
Xifaxan	Rifaximin	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Dupixent Pen	Dupilumab	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Trospium Chloride Er	Trospium Chloride	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Digoxin	Digoxin	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Linzess	Linaclotide	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Risperidone	Risperidone	11	suppressed
Topiramate	Topiramate	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error